Related Experiment Video
Updated: May 2, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Variability of the transferrin receptor 2 gene in AMD
Daniel Wysokinski1, Janusz Blasiak1, Mariola Dorecka2
1Department of Molecular Genetics, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Genetic variations in the Transferrin Receptor 2 (TFR2) gene may influence the occurrence of age-related macular degeneration (AMD), particularly in relation to obesity and age. These TFR2 gene polymorphisms could play a role in AMD development.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Oxidative stress is a key factor in age-related macular degeneration (AMD) pathogenesis.
- Iron overload can exacerbate oxidative stress via the Fenton reaction.
- Transferrin receptor 2 (TFR2) is crucial for iron homeostasis, and its gene variability may impact AMD risk.
Purpose of the Study:
- To investigate the association between TFR2 gene polymorphisms and the occurrence of AMD.
- To explore how TFR2 gene variations modulate AMD risk factors such as obesity and age.
Main Methods:
- Genotyping of 493 AMD patients and 171 controls for two TFR2 gene polymorphisms: c.1892C>T (rs2075674) and c.-258+123T>C (rs4434553).
- Statistical analysis to assess the correlation between genotypes, AMD occurrence, and modulation by risk factors like BMI and age.
Main Results:
- The c.1892C>T polymorphism showed an association with AMD, particularly the TT genotype in obese patients.
- The c.-258+123T>C polymorphism's CC genotype correlated with increased AMD frequency in individuals with BMI < 26.
- Age-specific effects were observed: TT genotype/T allele of c.1892C>T decreased AMD risk in those >72 years, while TC genotype/C allele increased it.
Conclusions:
- Specific polymorphisms in the TFR2 gene (c.1892C>T and c.-258+123T>C) may be associated with age-related macular degeneration.
- These genetic variations might influence AMD occurrence directly or by interacting with risk factors like obesity and age.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Drug toxicity: Idiosyncratic Reactions

